Member Profile
Michael Shelley
In silico drug design gives first model for selective PERK inhibition
Dr. Cardozo, the National Science Foundation (NSF)-funded researcher, and his team at NYU Sackler Institute have developed the first pharmacophore model for selective PERK inhibition as well as 14 selective... More »
About Me
I work in the mathematical modeling, analysis, and simulation of physical and biological systems. This has included problems arising in free-boundary problems in fluid dynamics and materials science, fluid-structure interactions arising from the physics of locomotion and adaptation, the dynamics of complex fluids in physics and biology, and in the computational neuroscience of vision.
